se of single dose intranasal fentanyl for the reduction of pain associated with retinopathy of prematurity screening :RCT
Phase 3
Completed
- Conditions
- Health Condition 1: null- Neonates 30-34 weeks postmenstrual age undergoing screening for retinopathy of prematurity.
- Registration Number
- CTRI/2017/12/011016
- Lead Sponsor
- Surya Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
Neonates 30-34 weeks postmenstrual age undergoing screening for retinopathy of prematurity
Exclusion Criteria
1.Infant receiving sedation or analgesic medications for any reason.
2.Infants on mechanical ventilation.
3.Any congenital malformations, or neurological dysfunction.
4.Parents refusing consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method